(2S,3R,4S,5S,6R)-2-[(2R,3S,4S,5R)-4,6-Dihydroxy-2-(hydroxymethyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

Metabolite details

Identifier

GRDHQWBQPQWUOG-LYDJVYILSA-N

InChI Key

GRDHQWBQPQWUOG-LYDJVYILSA-N

IUPAC name

Preferred name

(2S,3R,4S,5S,6R)-2-[(2R,3S,4S,5R)-4,6-Dihydroxy-2-(hydroxymethyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol

INN name

—

Synonym

beta-D-gluco-hexopyranosyl-(1->2)-[beta-D-gluco-hexopyranosyl-(1->4)]-D-gluco-hexopyranose

ChEBI

CHEBI:151408

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Unknown Metabolite Annotation in Mouse Aging using Ion Mobility Collision Cross-Section Atlas (AllCCS)

Observed in differential profiles

• 36_week_vs_104_week